1. Background
2. Objectives
3. Patients and Methods
3.1. Study Design
3.2. Study Population
3.3. Data Collection
3.3.1. Stages of the research
3.4. Data Analysis
3.4.1. Anti-HBs
3.4.2. Interpretation of the Results
3.4.3. Anti-HBc Total
3.4.4. Interpretation of the Results
3.4.5. Statistical Analysis
3.5. Ethical Aspects
4. Results
| No. (%) | |
|---|---|
| Do you know or have heard of Hepatitis B? | |
| No | 2 (1.1) |
| Yes | 177 (98.9) |
| Do you have or have you been diagnosed with hepatitis B? | |
| No | 176 (98.3) |
| Yes | 03 (1.7) |
| Hepatitis B in family history? | |
| No | 132 (73.7) |
| Yes | 07 (3.9) |
| I don’t know | 40 (22.3) |
| Are there risks for people who live with the virus carrier? | |
| No | 39 (21.8) |
| Yes | 120 (67.0) |
| I don’t know | 20 (11.2) |
| Is this disease curable? | |
| No | 62 (34.6) |
| Yes | 82 (45.8) |
| I don’t know | 35 (19.6) |
| Is there any vaccine against this disease? | |
| No | 02 (1.1) |
| Yes | 174 (97.2) |
| I don’t know | 03 (1.7) |
| Level of HBV virulence | |
| Low | 16 (8.9) |
| Medium | 51 (28.5) |
| High | 104, (58.1) |
| Ignored/No answer | 08, (4.5) |
| No. (%) | |
|---|---|
| Are you vaccinated against Hepatitis B? (n = 179) | |
| No | 17 (9.5) |
| Yes | 143 (79.9) |
| I don’t know | 19 (10.6) |
| If not why? (n = 36) | |
| No interest | 02 (5.6) |
| Forgetfulness | 18 (50.0) |
| Other | 06 (16.7) |
| No answer | 10 (27.8) |
| Took all doses? (n = 143) | |
| No | 33 (23.1) |
| Yes | 98 (68.5) |
| I don’t know | 12 (8.4) |
| How many doses did you get? (n = 143) | |
| 1 dose | 02 (1.4) |
| 2 doses | 07 (4.9) |
| 3 doses | 89 (62.2) |
| No answer/Ignored | 45 (31.5) |
| How many doses should be taken? (n = 179) | |
| 1 dose | 04 (2.8) |
| 2 doses | 04 (2.8) |
| 3 doses | 125 (87.4) |
| 4 doses | 03 (2.1) |
| No answer/Ignored | 43 (4.9) |
| How long has it been since the completion of the vaccination schedule? (n = 143) | |
| ≤ 6 months | 13 (9.1) |
| > 6 months | 85 (59.4) |
| No answer/Ignored | 45 (31.5) |
| Did you Know or have heard about Anti-HBs test? (n = 179) | |
| No | 92 (51.4) |
| Yes | 87 (48.6) |
| If Yes, where did you obtain this information (n = 87) | |
| University classes | 70 (80.5) |
| In articles, books etc. | 18 (20.7) |
| Internet | 11 (12.6) |
| Other | 01 (1.2) |
| Specialized establishments | 07 (8.0) |
| Have you had the Anti-HBs test ?(n = 179) | |
| No | 169 (94.4) |
| Yes | 10 (5.6) |
| If not why? (n = 169) | |
| I don’t know the test | 81 (47.9) |
| Forgetfulness | 33 (19.5) |
| I don’t have no interest | 02 (1.2) |
| Other | 45 (26.6) |
| No answer/Ignored | 08 (4.7) |
| If Yes, how long after the last dose of vaccination? (n = 10) | |
| ≥ 6 months | 02 (20.0) |
| < 6 months | 08 (80.0) |
4.1. Laboratorial Step
4.2. Bivariate Analysis
| Variables | Anti-Hbs | Total, No. (%) | RP a (CI a 95%) | P value b | |
|---|---|---|---|---|---|
| Positive No. (%) | Negative No. (%) | ||||
| Gender | 0.888 | ||||
| Female | 67 (78.8) | 18 (21.2) | 85 (100.0) | Ref a | |
| Male | 59 (79.7) | 15 (20.3) | 74 100.0 | 0.96 (0.48-1.90) | |
| Age | 0,320 | ||||
| 18 - 20 years old | 31 (81.6) | 07 (18.4) | 38 100.0 | ref. | |
| 21 - 23 | 75 (81.5) | 17 (18.5) | 92 100.0 | 0.77 (0.39-1.53) | |
| ≥ 24 | 20 (69.0) | 09 (31.0) | 29 100.0 | 1.68 (0.78-3.61) | |
| Number of doses | 0.122 c | ||||
| 1 dose | 01 (50.0) | 01 (50.0) | 02 100.0 | ref. | |
| 2 doses | 05 (71.4) | 02 (28.6) | 07 100.0 | 2.13 (0.47-9.61) | |
| 3 doses | 70 (87.5) | 10 (12.5) | 80 100.0 | 0.37 (0.10-1.36) | |
| Time of vaccination conclusion | 0.444 c | ||||
| ≤ 6 months | 11 (91.7) | 01 (8.3) | 12 100.0 | ref. | |
| > 6 months | 65 (84.4) | 12 (15.6) | 77 100.0 | 1.87 (0.24-14.38) | |
a Abbreviations: CI, confidence interval; RP, ratio of prevalence; ref, reference category
b Chi-square Test χ²
c FISHER
